SUBSCRIBE
SUBSCRIBE
News   Business

Accium BioSciences, Inc. Takes $3 Million Series A

January 6, 2006 | 
1 min read
Accium BioSciences, a provider of bioanalytical services with a focus on early-stage drug development, has raised $3 million in a Series A round.
Startups
MORE ON THIS TOPIC
Business people and concepts vector art exit
Cell therapy
Galapagos Exits Cell Therapy, Cuts 365 Employees
October 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Hand holding a lung shape symbol against a blue background. World tuberculosis day, world no tobacco day, lung cancer, pulmonary hypertension, pneumonia
Lung cancer
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss
October 21, 2025
 · 
2 min read
 · 
Tristan Manalac
business graph chart finance stock market collage hand halftone trendy. vector illustration concept growth investment exchange currency money financial. technology digital background profit trade.
Metabolic disorders
Ascendis Skids as FDA Detects Death in Patient on Yorvipath
October 21, 2025
 · 
1 min read
 · 
Tristan Manalac
Illustration showing hands holding arrow that goes up and down a few times and ends up in upward direction
Mergers & acquisitions
Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking
October 20, 2025
 · 
2 min read
 · 
Tristan Manalac